Exelixis, Inc. (EXEL)
43.86
-0.18
(-0.41%)
USD |
NASDAQ |
Dec 31, 15:10
Exelixis Price: 43.86 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vanda Pharmaceuticals, Inc. | 8.90 |
| ADMA Biologics, Inc. | 18.22 |
| Aldeyra Therapeutics, Inc. | 5.13 |
| Neurocrine Biosciences, Inc. | 141.80 |
| Axsome Therapeutics, Inc. | 183.50 |
Price Related Metrics
| PE Ratio | 18.47 |
| PS Ratio | 5.485 |
| PEG Ratio | 0.3594 |
| Price to Book Value | 5.442 |
| Price to Free Cash Flow | 16.10 |
| Earnings Yield | 5.42% |
| Market Cap | 11.76B |
| PEGY Ratio | 0.3594 |
| Operating PE Ratio | 15.30 |
| Normalized PE Ratio | 18.08 |